AZ1 Inhibitors
AZ1 inhibitors constitute a class of chemical compounds that have attracted attention within the domain of molecular biology and cellular signaling research. These inhibitors are specifically designed to target and modulate the activity of AZ1, a protein with a role in cellular processes related to signal transduction and gene regulation. While AZ1 has been linked to several cellular functions, it is particularly noteworthy for its involvement in the regulation of gene expression and chromatin remodeling.
The function of AZ1 inhibitors revolves around their ability to interfere with the molecular interactions and activities of AZ1. By doing so, these inhibitors can impact processes such as transcriptional regulation and chromatin dynamics, ultimately influencing gene expression patterns. Researchers utilize AZ1 inhibitors as valuable tools to probe the specific roles of AZ1 in these cellular processes, providing insights into the intricate molecular mechanisms governing gene regulation and chromatin remodeling. While the precise applications and broader implications of AZ1 inhibitors continue to be subjects of ongoing research, their utility in advancing our understanding of cellular signaling and gene expression dynamics is undeniable within the field of molecular biology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Difluoromethylornithine | 70052-12-9 | sc-204723 sc-204723A sc-204723B sc-204723C sc-204723D sc-204723E | 10 mg 25 mg 100 mg 250 mg 1 g 5 g | $59.00 $133.00 $161.00 $317.00 $983.00 $4821.00 | 2 | |
As an irreversible inhibitor of ODC, DFMO might increase OAZ1 turnover, thus reducing its level indirectly. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with the translocation step, potentially reducing OAZ1 protein levels. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA at the transcription initiation complex, inhibiting RNA synthesis, possibly affecting OAZ1 mRNA. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Causes premature chain termination during protein synthesis, possibly lowering the synthesis of OAZ1 protein. | ||||||
Acivicin | 42228-92-2 | sc-200498B sc-200498C sc-200498 sc-200498D | 1 mg 5 mg 10 mg 25 mg | $104.00 $416.00 $655.00 $1301.00 | 10 | |
An inhibitor of several enzymes involved in amino acid metabolism, could indirectly affect OAZ1 expression. | ||||||
Aminoguanidine hydrochloride | 1937-19-5 | sc-202931 sc-202931A sc-202931B | 10 g 25 g 50 g | $32.00 $43.00 $94.00 | 2 | |
As a diamine oxidase inhibitor, it may increase intracellular polyamine levels, potentially altering OAZ1 expression. | ||||||
Hydralazine-15N4 Hydrochloride | 304-20-1 (unlabeled) | sc-490605 | 1 mg | $480.00 | ||
A vasodilator that can influence cellular metabolism, might have off-target effects that reduce OAZ1 expression. | ||||||
Methylglyoxal solution | 78-98-8 | sc-250394 sc-250394A sc-250394B sc-250394C sc-250394D | 25 ml 100 ml 250 ml 500 ml 1 L | $146.00 $437.00 $478.00 $754.00 $1446.00 | 3 | |
A glycolysis byproduct that modifies proteins and nucleic acids, potentially affecting OAZ1 expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Dihydrofolate reductase inhibitor, reduces nucleotide synthesis and could indirectly affect OAZ1 mRNA synthesis. | ||||||
Streptozotocin (U-9889) | 18883-66-4 | sc-200719 sc-200719A | 1 g 5 g | $116.00 $530.00 | 152 | |
A glucosamine-nitrosourea that can cause DNA alkylation and might influence OAZ1 expression indirectly. | ||||||